Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 01 - 05 crawled time : 14:30 save search
USA Truck Selects Nikola & Thompson Truck Centers
Published: 2022-01-05 (Crawled : 14:30) - usa-truck.com
USAK 4 | $31.71 0.06%
|
Transportation
|
| O: 3.4%
H: 0.0%
C: -5.41%
NKLA | $0.6637 0.56% 7.6M
|
Consumer Durables
|
| O: 3.49%
H: 7.77%
C: -7.49%
truck
Cue Biopharma and LG Chem Life Sciences Announce Development Milestone in Immuno-STAT Biologics Collaboration for CUE-102
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
CUE | $1.58 21K
|
Health Technology
|
| O: 0.34%
H: 2.36%
C: -8.78%
cue-102 biopharma collaboration life science milestone
Inhibikase Therapeutics Highlights 2022 Pipeline Goals and Milestones
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
IKT | News | $2.1 3.1K
|
Health Technology
|
| O: -1.83%
H: 2.48%
C: -6.83%
als therapeutics milestone
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research StudyThe study will evaluate the impact of high-resolution genomes generated on PacBio technology in studying unsolved rare disease cases
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
PACB | $1.49 2.05% 1.5M
|
Health Technology
|
| O: -0.21%
H: 1.06%
C: -10.24%
technology research disease rare
Neovasc Announces First Patient Enrollment in COSIRA-II Trial
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
NVCN | $30.03 1.66% -2.02% 0
|
Health Technology
|
| O: 3.14%
H: 0.06%
C: -7.93%
cosira-ii trial enroll
Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
commercialization analytics
NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA® (tivozanib) for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: -12.16%
nkt2152 fotivda treatment renal trial therapeutics cel collaboration cell carcinoma
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
MYMD | $2.52 6.8K
|
Manufacturing
|
| O: 0.0%
H: 1.75%
C: -5.26%
als ces patent
Esports Entertainment Group Renews Partnership with Take-Two’s NBA 2K League
Published: 2022-01-05 (Crawled : 14:30) - esportsentertainmentgroup.com
GMBL | $0.75 8.5K
|
Consumer Services
|
| O: -1.72%
H: 0.59%
C: -8.5%
partnership group
DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
WVE | $4.99 3.96% 34K
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: -8.92%
DMAC | $2.49 1.4K
|
Health Technology
|
| O: 0.79%
H: 2.89%
C: -6.82%
therapeutics
Looking Back on 2021
Published: 2022-01-05 (Crawled : 14:30) - chf-solutions.com
PINC | News | $21.04 1.2% 76K
|
Health Services
|
| O: 0.29%
H: 0.43%
C: -1.17%
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
TMO | News | $542.82 0.24% 190K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
acquisition
Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
CYRX | $16.46 -0.06% 15K
|
Transportation
|
| O: -0.7%
H: 0.74%
C: -7.79%
health thc conference cryo
Exelixis Announces Enrollment Completion in Phase 3 CONTACT-03 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Previously Treated Metastatic Renal Cell Carcinoma
Published: 2022-01-05 (Crawled : 14:30) - biospace.com/
TAK | News | $13.235 0.57% 100K
|
Health Technology
|
| O: 0.07%
H: 0.8%
C: -1.67%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: -0.43%
H: 1.5%
C: -3.43%
ntact-03 renal trial cel phase 3 enroll cell carcinoma
Check-Cap Issues Letter to Shareholders
Published: 2022-01-05 (Crawled : 14:30) - ir.check-cap.com
CHEK | $2.26 8.5K
|
Health Technology
|
| O: 0.84%
H: 0.06%
C: -3.67%
Digerati Closes Acquisition of SkyNet Telecom
Published: 2022-01-05 (Crawled : 14:30) - globenewswire.com
DTGI | $0.0239 -26.46% 0
|
Information
|
| O: 0.0%
H: 15.68%
C: 3.16%
acquisition
Intrado Acquires Permission Click
Published: 2022-01-05 (Crawled : 14:30) - globenewswire.com
APO | News | $108.5 1.12% 95K
|
Finance
|
| O: 1.11%
H: 0.08%
C: -6.43%
permission
Franklin BSP Lending Corporation and Franklin BSP Capital Corporation, Affiliates of Benefit Street Partners, Acquire Encina Equipment Finance, LLC
Published: 2022-01-05 (Crawled : 14:30) - bsprealtytrust.com
BEN 4 | $25.235 0.86% 290K
|
Finance
|
| O: 0.85%
H: 0.0%
C: 0.0%
corporation
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.